Position in CRSP
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$15,018,950
-$8,490,999 QoQ
Shares Held
275,375
-44.3% QoQ
Ownership
0.285%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 521 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 51%
Shared 44%
None 4%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. CRSP ranks #65 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in CRSP
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,018,950 | 275,375 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $23,509,949 | 494,218 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $47,568,689 | 907,107 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $56,840,246 | 877,029 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $44,637,509 | 917,712 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $31,891,042 | 937,145 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $37,285,765 | 947,301 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $38,739,988 | 824,606 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $51,317,544 | 950,149 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $63,460,706 | 931,055 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $48,793,820 | 779,454 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $39,934,166 | 879,801 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $39,930,752 | 711,271 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $34,362,810 | 759,735 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $31,496,064 | 774,811 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $42,416,068 | 649,060 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $26,734,302 | 439,926 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $15,063,983 | 239,987 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $19,630,126 | 259,041 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $17,312,213 | 154,670 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $23,607,123 | 145,822 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $16,906,687 | 138,750 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $16,481,832 | 107,647 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $8,502,591 | 101,657 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,423,371 | 101,012 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $3,752,648 | 88,485 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||